Frazier Life Sciences Acquisition Corp II Class A FLSC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $10.27
- Day Range
- $10.27–10.32
- 52-Week Range
- $10.18–10.63
- Bid/Ask
- $10.28 / $10.34
- Shares Outstanding
- 9.68M
- Market Cap
- $99.65M
- Volume/Avg
- 20,001 / 207,640
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Frazier Life Sciences Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
- Sector
- Financial Services
- Industry
- Shell Companies
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- —
Valuation
|
Metric
|
FLSC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
FLSC
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.37 |
Interest Coverage | — |
Quick Ratio
FLSC
Profitability
|
Metric
|
FLSC
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Shell Companies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vylor Inc
VYLR
| LOCK|>@$$QJm | LOCK|GmP | $50B | |||
| Drugs Made In America Acquisition II Corp
DMII
| — | LOCK|l?$$K | $649M | |||
| EQV Ventures Acquisition Corp II Class A
EVAC
| — | LOCK|>GJ# | $604M | |||
| Bain Capital GSS Investment Corp Class A
BCSS
| — | LOCK|@@B$ | $596M | |||
| Cantor Equity Partners IV Inc Ordinary Shares - Class A
CEPF
| — | LOCK|s^g%! | $588M | |||
| Churchill Capital Corp XII Class A
CXII
| — | LOCK|!s | $574M | |||
| Churchill Capital Corp XI Common shares class A
CCXI
| — | LOCK|cbX | $571M | |||
| American Exceptionalism Acquisition Corp A Ordinary Shares-Class A
AEXA
| — | LOCK|^v$> | $530M | |||
| New America Acquisition I Corp Class A
NWAX
| — | LOCK|&dt% | $499M | |||
| Ares Acquisition Corp III Class A
AAC
| — | LOCK|l^PMp | $492M |
United States